Image by Dr Graham Beards at en.wikipedia, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=25206097
A small regulatory RNA found in many problematic bacteria, including Escherichia coli, appears to be responsible for managing the response of these bacteria to environmental stresses. Professor Charles Dozois from Institut national de la recherche scientifique (INRS) and doctoral student Hicham Bessaiah see a promising avenue for more effective treatment of antibiotic-resistant bacteria. Their results have been published in the journal PLOS Pathogens.
In conducting their work, the researchers and their team observed that the elimination of this regulatory RNA sequence had an effect on urinary tract infections related to E. coli. These infections are among the world's most common, especially in women, but they are sometimes hard to treat due to antibiotic resistance.
E. coli is normally found in the intestinal flora, but when it migrates to the bladder, the conditions there are completely different. The bacteria have to withstand the environmental stressors in order to cause a bladder infection. "Without the regulatory RNA, the bacteria is more sensitive to changes in the environment and loses its infectious capacity," explained the doctoral student.
The idea is to block the RNA and make the bacteria less infectious, especially in the case of chronic infection, which can lead to increased resistance to treatment. If the bacteria are less resistant to stress, it will be more vulnerable to the host's immune response. Regulation of the systems that make it virulent will also be disrupted.
"People with recurrent urinary tract infections take antibiotics regularly. This leads to resistance and limits treatment options, which is why it's important to find alternatives," explained Professor Dozois.
The relationship between virulence and stress isn't unique to urinary tract infections. The regulatory RNA sequence studied by the researchers is also found in a number of other major pathogenic bacteria. Given that the RNA seems to impact multiple functions, the research group is working to better understand the mechanisms of regulation before pursuing additional research on antibiotic-resistant strains of bacteria.
Journal Reference:
Hicham Bessaiah, Pravil Pokharel, Hamza Loucif, Merve Kulbay, Charles Sasseville, Hajer Habouria, Sébastien Houle, Jacques Bernier, Éric Massé, Julien Van Grevenynghe, Charles M. Dozois. The RyfA small RNA regulates oxidative and osmotic stress responses and virulence in uropathogenic Escherichia coli. PLOS Pathogens, 2021; 17 (5): e1009617 DOI: 10.1371/journal.ppat.1009617
Posted by Dr. Tim Sandle, Pharmaceutical Microbiology Resources (http://www.pharmamicroresources.com/)
The group of drug Called Rifamycin are used in such a way!
ReplyDeleteExample Refampicin is used in treatment of TB
Rifabutin is used in TB and HIV patients coz refampicin is an enzyme inducer when being used in HIV patients.
Refapentine also is used in such a way!
They block the the RNA Polymerization. Refampicin m blocks initiation of RNA synthesis by specifically inhibiting bacterial RNA polymerase. It does not interact with mammalian RNA polymerases, making it specific for Gram-positive bacteria and some Gram-negative bacteria.
The group of drug Called Rifamycin are used in such a way!
ReplyDeleteExample Refampicin is used in treatment of TB
Rifabutin is used in TB and HIV patients coz refampicin is an enzyme inducer when being used in HIV patients.
Refapentine also is used in such a way!
They block the the RNA Polymerization. Refampicin m blocks initiation of RNA synthesis by specifically inhibiting bacterial RNA polymerase. It does not interact with mammalian RNA polymerases, making it specific for Gram-positive bacteria and some Gram-negative bacteria.